
NCCN Updates Guidance for ICIs: What to Know
Immune checkpoint inhibitors (ICIs) have increasingly shifted toward frontline treatment in oncology, raising questions about how to optimize their use and manage associated toxicities to keep patients on treatment. At the 2025 National Comprehensive …